Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-27

Clinical Trial Update: Combined Triple Therapy in Diabetic Retinopathy (DRP) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a combined triple therapy for diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combined Triple Therapy

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Macular Edema, Diabetic Retinopathy | Phase 3 | Status: COMPLETED